Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
about
Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranosticsPhotodynamic therapy and the development of metal-based photosensitisersPhotodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.High-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal modelEndodontic antimicrobial photodynamic therapy: safety assessment in mammalian cell cultures.Choline PET for monitoring early tumor response to photodynamic therapyDiffusion-weighted MRI for monitoring tumor response to photodynamic therapy.Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trialMechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell deathDeep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates.Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.Choline Molecular Imaging with Small-animal PET for Monitoring Tumor Cellular Response to Photodynamic Therapy of Cancer.A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview.Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis.Photo-oxidation of cardiolipin and cytochrome c with bilayer-embedded Pc 4.Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft system.Photodynamic therapy with recombinant adenovirus AdmIL-12 enhances anti-tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model.Effect of photodynamic therapy combined with Celecoxib on expression of cyclooxygenase-2 protein in HeLa cells.
P2860
Q30462417-FC8AD60B-0FE7-4BAB-A218-078633161F42Q30493290-E6825FEE-5351-43D9-B5C8-76C49DE4D487Q33280687-73BDCD55-363A-4CA1-A242-5427C80E0DA7Q33303889-AF13BB23-5EB3-46D1-930B-FADFDA21A148Q33511391-166A8E53-1471-420D-B2E6-04899FC9F8ADQ33518345-138C6311-F8D0-439C-8D7B-08E26150858DQ33647190-1404A8D7-A254-448B-9077-DD757147962FQ33796958-0A0FD811-64FE-47E0-8FE2-3EFC6AC22331Q33939339-F6E3D39A-4343-4D51-B57E-7320D035FD05Q34664629-416A5D72-A3AC-4CAB-A429-5192473825F3Q35971100-BF07BE99-44F9-43D0-B679-66237CF7EDF0Q36537257-A3B67A33-FF72-403E-9773-D4CE64F13098Q37190425-2369FEBD-A6CC-48C0-9E8A-694D9EFB2E9CQ39799148-97BB6C47-E283-44A9-90DF-940C628FB0BCQ40817417-6F76C8A5-E8B4-420F-B1A9-7BAAB5EEEA8EQ41771610-00246457-B45C-44FB-84C7-E88C56059894Q41932696-511EB24C-E01A-4751-8F19-2E4AE32D95E8Q53543726-B34AB863-BF51-4C67-BABD-38B3CB59FBE7Q55114094-1B795D9F-BEC8-46AF-84AC-79AB93EB9423
P2860
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
@ast
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
@en
type
label
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
@ast
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
@en
prefLabel
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
@ast
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
@en
P2093
P1476
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
@en
P2093
Colussi VC
Mulvihill JW
Oleinick NL
P304
P356
10.1562/0031-8655(1999)069<0236:PPTOHO>2.3.CO;2
P577
1999-02-01T00:00:00Z